Evidence map

ReviewMolecular therapy. Oncology2026

Mesothelin biology and the evolving landscape of targeted immunotherapy.

Remy Boisgard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41994562